The Editors of AI in Precision Oncology - the groundbreaking new peer-review journal from Mary Ann Liebert, Inc. — are thrilled to welcome you to the journal's second annual virtual summit: The State of AI in Precision Oncology.

Artificial Intelligence (AI) is rapidly changing the practice of medicine in general and oncology in particular. Clinicians are beginning to deploy a range of AI applications and strategies to transform their practice, personalize treatments and save patient lives.

For this 2024 virtual summit, Founding Editor-in-Chief Dr. Doug Flora and colleagues have invited a group of trail-blazing physicians, oncologists, and AI thought leaders to assess the state of AI in the field of precision oncology through a series of keynote presentations, panel discussions, and fireside chats.

• An opening keynote from Debra Patt, MD, PhD (Exec VP, Texas Oncology)
• A keynote conversation with Caroline Chung, MD (VP/Chief Data Officer, MD Anderson Cancer Center)
• Fireside chats with leading oncology experts and AI evangelists including Sanjay Juneja, MD (Tempus AI); Sean Khozin, MD (CEO, Roundtable on Cancer); Rajeev Ronanki (CEO, Lyric); and Vivek Subbiah, MD (Chief, Early-Phase Drug Development, Sarah Cannon Research Institute)
• A presentation from personalized medicine pioneer Leroy Hood, MD, PhD (CEO, Phenome Health)
• Breakout sessions organized by summit sponsors
• Closing comments from Doug Flora, MD and special guests

The State of AI in Precision Oncology summit is entirely free to register.